However, to our knowledge, the effect of the pharmacological activation of KvLQT1 (i.e., KvLQT1 activator delivered directly to the lung) on the resolution of ARDS parameters has never been investigated in an animal model of ALI. This evidence concerns the gene KCNQ1 and acute respiratory distress syndrome.